ALSO IN THIS MONTH'S ISSUE

• From Academia to Industry – How Biopharma Entrepreneurship Became A Calling

  While I knew that I wanted to dedicate my life to developing gene therapies to cure human diseases, I could not have predicted that I would leave academia to become an entrepreneur.

• How To Identify Capital To Fund Life Sciences Growth

  For life sciences companies, funding needs evolve at every stage of growth — creating both challenges and opportunities. Regardless of the stage, it is fundamental to align your funding strategy with your company’s vision.

• Don’t Overlook The Risks Of Innovative Clinical Trials

  Advancements in AI and machine learning (ML) for data collection and interpretation could increase the threat of cyber-attacks and malicious hacking of private medical data. As such, sponsors shouldn’t overlook the liability risk of such advancements and the corresponding changes that should be made to business insurance.

• Readying For Commercialization

  Commercialization planning is particularly important in today’s continuously evolving biopharma marketplace. Not only do you have to manage and allocate capital appropriately but also manage and mitigate the inherent risks in the process — to the extent possible.